European Respiratory Review

Issues surrounding first chronic
therapies in asthma

Proceedings of a symposium sponsored by Zeneca Pharmaceuticals
at Interasma, Montpellier, April 1996

Edited by P. Barnes

CONTENTS

P. Barnes	309	Introductory remarks
R. Pauwels	310	The potential for antileukotriene drugs as first-line chronic therapy
L.A. Laitinen	313	Comparative clinical data in mild asthma populations
N. Barnes	316	Do treatment guidelines reflect reality?
J. Bousquet	318	Factors affecting compliance in patients with mild asthma
M. Aubier	321	Issues concerning the anti-inflammatory treatment of mild asthma

Manuscripts